Page 6 - Cancer Update Spring 2019 Vol. 8 Issue 1
P. 6
4
BAYLOR CHARLES A. SAMMONS CANCER CENTER
CURRENT CLINICAL TRIALS
Site Study ID Location Principal Investigator
Breast
GI
017-478
Baylor Dallas
Texas Oncology - Dallas
Texas Oncology - Dallas
Joyce A. O’Shaughnessy, MD
T01797
Texas Oncology - Dallas
Joyce A. O’Shaughnessy, MD
18004
Texas Oncology - Dallas
Joyce A. O'Shaughnessy, MD
18042
Texas Oncology - Dallas
Joanne Blum, MD, PhD, FACP
Lung
17199
Texas Oncology - Dallas
Kartik Konduri, MD
17201
Texas Oncology - Dallas
Kartik Konduri, MD
T01763
Kartik Konduri, MD
17186
A. David McCollum, MD
13195
Texas Oncology - Dallas
Carlos H.R. Becerra, MD
18016 STAR
Texas Oncology - Dallas
A. David McCollum, MD
GU
15180
Texas Oncology - Dallas
Thomas E. Hutson, DO, PharmD
T01761
Texas Oncology - Dallas
Thomas E. Hutson, DO, PharmD
Head & Neck
017-075
Baylor Dallas
Eric Nadler, MD, MPP
8 / Innovative Immuno-Oncology Clinical 13 / A Multidisciplinary Approach 23 / Neuroendocrine Cancer in the Skin: A Publication for Baylor Scott & White Health’s Oncology Program Trial Using Natural Killer Cells to Neuroendocrine Cancer Merkel Cell Carcinoma
